Compare ITI Pharma and Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Details
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.35 | 1.93 |
NAV | ₹16.47 | ₹37.55 |
Fund Started | 18 Oct 2021 | 25 Jun 2018 |
Fund Size | ₹208.21 Cr | ₹5024.00 Cr |
Exit Load | Exit load of 1% if redeemed within 12 months. | Exit load of 1% if redeemed within 15 days. |
Returns
1 Year | 46.17% | 50.65% |
3 Year | 17.95% | 22.29% |
5 Year | - | 30.36% |
Holding Analysis
Equity | 98.20% | 97.87% |
Cash | 1.80% | 2.13% |
Top Holdings
Top 10 Holdings |
|
|
Fund Manager
Name | Dhimant Shah | Dharmesh Kakkad |
Start Date | 01 Dec 2022 | 23 Feb 2021 |
About Fund
Description | The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 18 Oct 2021 | 25 Jun 2018 |
